Acerus Pharmaceuticals Corporation Aktie Toronto S.E.
Aktien
A3DHGW
CA00444G4051
ASP
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01.05.18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17.07.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09.09.13 |
Borys Chabursky
BRD | Director/Board Member | - | 20.12.15 |
% 1. Jan. | Kap. | |
---|---|---|
+29,98 % | 682 Mrd. | |
+32,39 % | 586 Mrd. | |
-3,52 % | 364 Mrd. | |
+18,59 % | 327 Mrd. | |
+4,07 % | 285 Mrd. | |
+16,50 % | 240 Mrd. | |
+9,56 % | 209 Mrd. | |
-9,04 % | 203 Mrd. | |
+7,09 % | 165 Mrd. |